Pegfilgrastim 6MG/.06ML (INJ, soln, SYR or autoinjector) and VMI
Active Definitive Contract Awarded Last action
- Contract number
- 75A50325C00002
- Awardee
-
Accord Biopharma, Inc. UEI M3PMHL5VML74
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $19,420,700
Award facts
- Opportunity
-
- Pegfilgrastim with VMI Solicitation · 75A50324R00004 · Posted Sep 13, 2024
- Contract value 43% obligated
-
- $19,420,700.00 Current, with exercised options
- $45,162,200.00 Potential, with all options
- Completion date 32% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Redwood City, CA 94065, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Novation Agreement | $7,615,500 | |
| Novation Agreement | $0 | |
| Original award | $11,805,200 |
About this award
The U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), through the Center for the Strategic National Stockpile (SNS), awarded a definitive firm fixed-price contract to Accord Biopharma, Inc. on March 19, 2025, with a ceiling value of $45.2 million. The contract covers the procurement and vendor-managed inventory (VMI) services for pegfilgrastim 6MG/.06ML in injection, solution, syringe, or autoinjector formats, with an ultimate completion date of March 18, 2030. The solicitation, posted on September 13, 2024, sought proposals for up to 60,300 units and included a one-year base period with four optional twelve-month ordering periods. Performance will be conducted in Redwood City, California. This full and open competition utilized no small business set-aside and is being administered under NAICS code 325412.
The Strategic National Stockpile maintains the nation's largest supply of potentially life-saving pharmaceuticals and medical supplies for emergency response, and pegfilgrastim is a critical biopharmaceutical used to support patients during chemotherapy and other medical treatments. Accord Biopharma's contract will ensure the SNS maintains adequate inventory of this essential medication and related services to support pandemic preparedness and emergency response capabilities. The government reserved the right to conduct discussions with offerors, though the solicitation anticipated award without discussions.
Quick answers
Who was awarded contract 75A50325C00002?
75A50325C00002 was awarded to Accord Biopharma, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on March 19, 2025.
How much is contract 75A50325C00002 worth?
The government has obligated $19,420,700 on 75A50325C00002. Its potential value, with all options, is $45,162,200.
Was contract 75A50325C00002 competed?
The extent of competition for 75A50325C00002 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award